Pressure volume loop study for valve disease
Part of Heart & circulation clinical trials.
This trial uses a special heart test called pressure volume loop assessment to better understand how well your heart pumps when you have severe valve disease. It aims to find patterns that may help doctors treat you more effectively. You may join if you have certain types of severe heart valve problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must have severe heart disease that affects at least one heart valve, such as moderate to severe or severe leakage of the mitral valve, severe leakage of the tricuspid valve, or significant narrowing or leakage of the pulmonary valve
- You must not be pregnant or breastfeeding
- You must not have any legal guardianship or protection orders
- You must not have certain conditions that make right heart catheterization unsafe, such as a blocked large vein near the heart, a mass in the right side of your heart, or severe narrowing of the tricuspid valve
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects data from people already scheduled for a right heart catheterization, a procedure that measures pressure inside the heart. The information gathered may help doctors better understand heart conditions and improve future care.
This study enrolls adults in the hospital with certain heart valve problems to track their health over time. It may help doctors better understand how valve disease behaves and what outcomes look like in real life.
This study is following people with heart valve disease (leaky or narrowed valves) to understand how the disease changes over time and what problems it may cause. It does not test a new treatment, but helps doctors learn more about valve disease progression.
This trial uses advanced CT scans to study people with moderate or severe heart valve disease. It aims to better understand valve problems and may help guide future treatments.
This study looks at pulmonary hypertension—high blood pressure in the lung arteries—in people with certain heart conditions (heart failure with preserved or reduced pumping function, or significant valve disease). It may help doctors better understand how lung blood pressure changes in these heart problems and guide care.
This study looks at people with moderate to severe heart valve disease (aortic, mitral, or tricuspid) who had at least two echocardiograms. It aims to learn more about how these conditions are managed in everyday medical practice.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.